Milica Margeta, M.D., Ph.D.

Research Summary

Center/Research Area Affiliations

Research Summary

Dr. Margeta specializes in glaucoma, which is a chronic blinding disease characterized by gradual loss of retinal ganglion cells and cupping of the optic nerve. Elevated intraocular pressure remains the only modifiable risk factor for glaucoma; currently there no treatments conferring retinal ganglion cell neuroprotection or reversing existing visual field loss. As a Harvard-Vision Clinical Scientist Development Program (K12) scholar, Dr. Margeta is investigating the role of retinal neuroinflammation in the pathogenesis of glaucoma, with the goal of developing novel neuroprotective treatments for this progressive blinding disease.